Madhya Pradesh Takes Government Hospitals Paperless Under HIMS
Madhya Pradesh began taking government hospitals paperless on 1 November under a ₹300-crore HIMS project; Indore logged 1,771 digital OPD registrations.
News
Sanofi India Q3 Profit Jumps 54% to ₹117 Crore as Insulin Grows 9% and Public Sector Sales Surge 85%; ₹75 Interim Dividend
Sanofi India’s Q3 2026 profit rose 53.6% to ₹117 crore on revenue of ₹491.7 crore, as its insulin portfolio grew 9% and public sector sales jumped 85% on new analogue accounts. EBITDA margin widened to 32.8% and the board declared a ₹75 interim dividend.
Mulk Technology Teams Up With OnClarity USA on ABDM-Ready AI Digital Hospital Platform With 22 Modules
Mulk Technology and OnClarity USA have launched an AI-enabled, ABDM-compliant digital hospital platform that puts EMR, lab, radiology, pharmacy, billing, claims, telehealth and a 40-language patient assistant on a single database.
Sun Pharma’s ILUMYA Wins US FDA Approval for Psoriatic Arthritis, Extending IL-23 Biologic Beyond Plaque Psoriasis
The US FDA has approved Sun Pharma’s sBLA for ILUMYA (tildrakizumab-asmn) in adults with active psoriatic arthritis, backed by the Phase 3 INSPIRE-1 and INSPIRE-2 studies. The provider-administered IL-23 inhibitor, approved for plaque psoriasis since 2018, now addresses a US PsA population of about 2.4 million.
Pune’s INSIGHT – The Mind Clinic Brings Nihilent’s Emoscape Emotion AI Into Psychiatric Assessment
INSIGHT – The Mind Clinic, Pune, led by psychiatrist Dr Hamza Hussain, has integrated Nihilent’s Emoscape emotion AI platform into its psychiatric and psychological assessments, using a one-minute webcam interaction to generate structured emotional profiles.
Alivus Life Sciences Q2 FY27 Profit Jumps 51% to Rs 197 Crore; CDMO Revenue Up 80% as Solapur API Site Nears Start
Alivus Life Sciences (formerly Glenmark Life Sciences) posted Q2 FY27 revenue of Rs 682 crore, up 16%, and PAT of Rs 197 crore, up 51.3%. Non-Glenmark sales rose 20.8% to 79% of revenue, CDMO revenue grew about 80% to Rs 50 crore, and Solapur Phase 1 goes live in Q3 FY27.
AIIA Launches National Ayurveda AI Challenge on IIT Bombay’s AyurParam LLM, Sets Up ‘AI in Ay’ Secretariat
AIIA, New Delhi, has launched AyushTech Innovate, a national open AI challenge on IIT Bombay’s AyurParam LLM, signed an MoU to set up an AI in Ayurveda secretariat, and opened an IPR facility for Ayurveda innovators.
India’s Pharma Exports Rise 4.9% to $16.14 Billion in H1 FY27 as Europe, ASEAN Offset Softer US Shipments
India’s pharmaceutical exports grew 4.90% to USD 16.14 billion in April–September 2026, Pharmexcil data shows. Q2 exports rose 3.05% to USD 8.04 billion, Europe climbed 9.66% to USD 3.29 billion, ASEAN rose 21.54% and bulk drugs grew 12.07%, while US shipments moderated.
Apollo Hospitals Bannerghatta Road Brings Da Vinci 5 Robotic Surgery With Force Feedback to Bengaluru
Apollo Hospitals, Bannerghatta Road, Bengaluru, is among the first in India to adopt Intuitive’s Da Vinci 5 robotic surgical system, now used across cardiac, oncology, gynaecology, GI and urology surgery.
Strides Pharma Q2 FY27 Revenue Rises 17% to ₹1,430 Crore as Ex-US Markets Overtake US Business for the First Time
Strides Pharma Science grew Q2 FY27 revenue 17% to ₹1,429.7 crore. Ex-US markets rose 31% to ₹696 crore, passing the US business (₹686 crore, +9%) in quarterly revenue for the first time, while EBITDA crossed ₹250 crore and margins eased to 17.6%.
Agilus Diagnostics Showcases Microbira’s Under-Three-Minute AI Microbial ID to Scotland Delegation, Eyes AMR Collaboration
Agilus Diagnostics hosted Scotland Secretary Douglas Alexander at its Mumbai lab to demonstrate Edinburgh-based Microbira’s AI-driven microbial identification platform, which names pathogens in under three minutes after culture, as both sides explore collaboration on antimicrobial resistance.
Senores Pharmaceuticals Plans ₹43 Crore Capacity Expansion Across US and India, Adds Prefilled Syringe Line
Senores Pharmaceuticals will expand capacity at its US subsidiary Havix from 1.2 billion to 2 billion units a year and at Apnar Pharma in India from 0.5 billion to 1.2 billion units, and add a 2.7 million-unit prefilled syringe line at Ratnatris, for an estimated ₹43 crore by March 2027.
Ayushman Bharat Delivers ₹291 Crore in Care to 1.8 Lakh Patients in West Bengal Since August Rollout
AB-PMJAY has delivered ₹291 crore in treatment to about 1.8 lakh patients in West Bengal since its 16 August launch in the state, with 4.13 crore health cards issued and 4,600 patients treated outside the state.
